3상완료

Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

연구 개요

The purpose of this study is to confirm the efficacy and the safety of Avanafil 100mg, 200mg or placebo administered orally for 12 weeks in patients with erectile dysfunction. The efficacy is evaluated by IIEF, SEP Q2 and Q3 and GEAQ and the safety is evaluated by laboratory tests, vital signs, physical examination and adverse events.

스폰서
리드: JW중외제약
적응증
Erectile Dysfunction
중재
Avanafil, Avanafil, Placebo
목표 등록
208
시작일
2009-03-01
완료(예정)
2009-11-01

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.